A rating of 22 puts OncoCyte Corp (OCX) near the bottom of the Biotechnology industry according to InvestorsObserver. OncoCyte Corp's score of 22 means it scores higher than 22% of stocks in the industry. OncoCyte Corp also received an overall rating of 34, putting it above 34% of all stocks. Biotechnology is ranked 29 out of the 148 industries.
What do These Ratings Mean?
Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 34 means the stock is more attractive than 34 percent of stocks.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.
What's Happening With OncoCyte Corp Stock Today?
OncoCyte Corp (OCX) stock is up 3.23% while the S&P 500 has fallen -0.51% as of 11:36 AM on Friday, Sep 18. OCX has gained $0.05 from the previous closing price of $1.55 on volume of 271,925 shares. Over the past year the S&P 500 is higher by 11.07% while OCX has fallen -27.27%. OCX lost -$0.51 per share the over the last 12 months.
Click Here to get the full Stock Score Report on OncoCyte Corp (OCX) Stock.
